•
US-based Mustang Bio, Inc. has announced a strategic partnership with uBriGene (Boston) Biosciences Inc., the US subsidiary of China-based uBriGene, a leading cell and gene therapy contract development and manufacturing organization (CDMO). This deal will result in the sale of Mustang’s development, manufacturing, and analytical testing facility in Worcester, Massachusetts…